Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study.

Hagen CP, Vestergaard S, Juul A, Skakkebæk NE, Andersson AM, Main KM, Hjøllund NH, Ernst E, Bonde JP, Anderson RA, Jensen TK.

Fertil Steril. 2012 Dec;98(6):1602-8.e2. doi: 10.1016/j.fertnstert.2012.08.008. Epub 2012 Sep 6.

PMID:
22959460
2.

Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years.

Steiner AZ, Herring AH, Kesner JS, Meadows JW, Stanczyk FZ, Hoberman S, Baird DD.

Obstet Gynecol. 2011 Apr;117(4):798-804. doi: 10.1097/AOG.0b013e3182116bc8.

3.

Is Anti-Müllerian Hormone Associated With Fecundability? Findings From the EAGeR Trial.

Zarek SM, Mitchell EM, Sjaarda LA, Mumford SL, Silver RM, Stanford JB, Galai N, White MV, Schliep KC, DeCherney AH, Schisterman EF.

J Clin Endocrinol Metab. 2015 Nov;100(11):4215-21. doi: 10.1210/jc.2015-2474. Epub 2015 Sep 25.

4.

Does preoperative antimüllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis?

Stochino-Loi E, Darwish B, Mircea O, Touleimat S, Millochau JC, Abo C, Angioni S, Roman H.

Fertil Steril. 2017 Mar;107(3):707-713.e3. doi: 10.1016/j.fertnstert.2016.12.013. Epub 2017 Jan 12.

PMID:
28089574
5.

Caffeine intake and fecundability: a follow-up study among 430 Danish couples planning their first pregnancy.

Jensen TK, Henriksen TB, Hjollund NH, Scheike T, Kolstad H, Giwercman A, Ernst E, Bonde JP, Skakkebaek NE, Olsen J.

Reprod Toxicol. 1998 May-Jun;12(3):289-95.

PMID:
9628552
6.

Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis.

Tal R, Tal O, Seifer BJ, Seifer DB.

Fertil Steril. 2015 Jan;103(1):119-30.e3. doi: 10.1016/j.fertnstert.2014.09.041. Epub 2014 Oct 24. Review.

PMID:
25450298
7.

Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.

Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R.

Fertil Steril. 2013 May;99(6):1644-53. doi: 10.1016/j.fertnstert.2012.12.048. Epub 2013 Feb 5.

8.

Longitudinal changes in maternal serum concentrations of antimüllerian hormone in individual women during conception cycles and early pregnancy.

Hamilton K, Hadlow N, Roberts P, Sykes P, McClements A, Coombes J, Matson P.

Fertil Steril. 2016 Nov;106(6):1407-1413.e2. doi: 10.1016/j.fertnstert.2016.07.1113. Epub 2016 Aug 24.

PMID:
27565260
9.

A prospective cohort study of a woman's own gestational age and her fecundability.

Wildenschild C, Riis AH, Ehrenstein V, Hatch EE, Wise LA, Rothman KJ, Sørensen HT, Mikkelsen EM.

Hum Reprod. 2015 Apr;30(4):947-56. doi: 10.1093/humrep/dev007. Epub 2015 Feb 11.

10.

The association between circulating levels of antimüllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women.

Kristensen SL, Ramlau-Hansen CH, Andersen CY, Ernst E, Olsen SF, Bonde JP, Vested A, Toft G.

Fertil Steril. 2012 Mar;97(3):779-85. doi: 10.1016/j.fertnstert.2011.12.017. Epub 2012 Jan 13.

PMID:
22244782
11.

Evaluation of serum anti-Mullerian hormone as a biomarker of early ovarian aging in young women undergoing IVF/ICSI cycle.

Lin PY, Huang FJ, Kung FT, Chiang HJ, Lin YJ, Lin YC, Lan KC.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6245-53. eCollection 2014.

12.

High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers.

Leader B, Hegde A, Baca Q, Stone K, Lannon B, Seifer DB, Broekmans F, Baker VL.

Fertil Steril. 2012 Oct;98(4):1037-42. doi: 10.1016/j.fertnstert.2012.06.006. Epub 2012 Jul 6.

PMID:
22771028
13.

Adult and prenatal exposures to tobacco smoke as risk indicators of fertility among 430 Danish couples.

Jensen TK, Henriksen TB, Hjollund NH, Scheike T, Kolstad H, Giwercman A, Ernst E, Bonde JP, Skakkebaek NE, Olsen J.

Am J Epidemiol. 1998 Nov 15;148(10):992-7.

PMID:
9829871
14.

Antimüllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: a follow-up study.

Yarde F, Voorhuis M, Dólleman M, Knauff EA, Eijkemans MJ, Broekmans FJ.

Fertil Steril. 2013 Sep;100(3):831-8. doi: 10.1016/j.fertnstert.2013.05.009. Epub 2013 Jun 10.

PMID:
23755952
15.

Antimüllerian hormone as a predictor of good-quality supernumerary blastocyst cryopreservation among women with levels <1 ng/mL versus 1-4 ng/mL.

Kavoussi SK, Odenwald KC, Boehnlein LM, Summers-Colquitt RB, Pool TB, Swain JE, Jones JM, Lindstrom MJ, Lebovic DI.

Fertil Steril. 2015 Sep;104(3):633-6. doi: 10.1016/j.fertnstert.2015.06.007. Epub 2015 Jul 3.

16.

Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.

Lunsford AJ, Whelan K, McCormick K, McLaren JF.

Fertil Steril. 2014 Jan;101(1):227-31. doi: 10.1016/j.fertnstert.2013.08.052. Epub 2013 Sep 29.

PMID:
24083876
17.

Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients.

Su HC, Haunschild C, Chung K, Komrokian S, Boles S, Sammel MD, DeMichele A.

Cancer. 2014 Dec 1;120(23):3691-8. doi: 10.1002/cncr.28942. Epub 2014 Jul 31.

18.

Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women.

Wunder DM, Bersinger NA, Yared M, Kretschmer R, Birkhäuser MH.

Fertil Steril. 2008 Apr;89(4):927-33. Epub 2007 Jul 2.

PMID:
17603052
19.

Antimüllerian hormone and pregnancy loss from the Effects of Aspirin in Gestation and Reproduction trial.

Zarek SM, Mitchell EM, Sjaarda LA, Mumford SL, Silver RM, Stanford JB, Galai N, Schliep KC, Radin RG, Plowden TC, DeCherney AH, Schisterman EF.

Fertil Steril. 2016 Apr;105(4):946-952.e2. doi: 10.1016/j.fertnstert.2015.12.003. Epub 2015 Dec 17.

20.

Can anti-Mullerian hormone (AMH) predict the outcome of intrauterine insemination with controlled ovarian stimulation?

Bakas P, Boutas I, Creatsa M, Vlahos N, Gregoriou O, Creatsas G, Hassiakos D.

Gynecol Endocrinol. 2015 Oct;31(10):765-8. doi: 10.3109/09513590.2015.1025381. Epub 2015 Aug 18. Erratum in: Gynecol Endocrinol. 2015 Oct;31(10):833.

PMID:
26288100

Supplemental Content

Support Center